Apply safety and efficacy data from clinical trials of new and emerging agents to achieve an individualized, patient-centered approach to IBD management
|
|
|
|
|
|
Analyze potential approaches for positioning new and emerging therapies for UC
|
|
|
|
|
|
Evaluate complex clinical situations in which patients with IBD may benefit from management strategies, including novel therapies
|
|
|
|
|
|